Spiriva Respimat

Spiriva Respimat Thận trọng

tiotropium bromide

Nhà sản xuất:

Boehringer Ingelheim
Thông tin kê toa chi tiết tiếng Anh
Special Precautions
SPIRIVA RESPIMAT, as a once daily maintenance bronchodilator, should not be used for the initial treatment of acute episodes of bronchospasm or for the relief of acute symptoms. In the event of an acute attack, a rapid-acting beta-2-agonist should be used.
SPIRIVA RESPIMAT should not be used as a first-line treatment for asthma. Asthma patients must be advised to continue taking anti-inflammatory therapy, i.e. inhaled corticosteroids, unchanged after the introduction of SPIRIVA RESPIMAT, even when their symptoms improve.
Immediate hypersensitivity reactions may occur after administration of SPIRIVA RESPIMAT inhalation solution.
As with other anticholinergic drugs, SPIRIVA RESPIMAT should be used with caution in patients with narrow-angle glaucoma, prostatic hyperplasia or bladder-neck obstruction.
Inhaled medicines may cause inhalation-induced bronchospasm.
Because of drug plasma concentration increase in moderate to severe renal impairment patients (creatinine clearance of ≤ 50 mL/min), SPIRIVA use should be cautioned & monitored closely.
Patients must be instructed in the correct administration of SPIRIVA RESPIMAT. Care must be taken not to allow the solution or mist to enter into the eyes. Eye pain or discomfort, blurred vision, visual halos or coloured images in association with red eyes from conjunctival congestion and corneal oedema may be signs of acute narrow-angle glaucoma. Should any combination of these symptoms develop specialist advice should be sought immediately.
Miotic eye drops are not considered to be effective treatment.
Dry mouth, which has been observed with anti-cholinergic treatment, may in the long term be associated with dental caries.
SPIRIVA RESPIMAT should not be used more frequently than once daily.
SPIRIVA cartridges are to be used only with the RESPIMAT inhaler.
Effects on ability to drive and use machines: No studies on the effects on the ability to drive and use machines have been performed. The occurrence of dizziness or blurred vision may influence the ability to drive and use machinery.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in